These results, along with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 help the notion of focusing on ACKR3 as a singular strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Ailments. Investigate on conolidine is limited, https://helens739ogw5.win-blog.com/profile